glp 1 agonist small molecule A small-molecule oral of the human glucagon-like peptide-1 receptor Design, synthesis, and biological evaluation

Eric Smith, BS, is a PharmD candidate at Binghamton University School of Pharmacy and Pharmaceutical Sciences

and colleagues emphasize: "Treatment regimens are of no use if a patient does not take the medication or engage in the recommended behavior." For instance, patients who discontinue GLP-1 therapy for weight management often regain the weight they initially lost, undoing the metabolic progress they had made

The medical and pharmacy claims are linked using Datavant tokens with Social Determinant of Health (SDOH) information derived from additional non-claim sources

Cost Considerations Brand-name dual agonists (Mounjaro/Zepbound) cost $1,069 monthly compared to $969 to $1,349 for pure GLP-1 agonists (Ozempic/Wegovy)